Dr. Sheldon P. Rothenberg

"The good thing is that we have developed something that can help women avoid neural tube defects," says Dr. Sheldon P. Rothenberg, a professor of medicine and biochemistry at SUNY and leader of the research team.

The finding could lead to a test for the antibodies, to help identify women at high risk of neural tube defects."Companies may well want to develop such a test for clinical use," he says.

"The good thing is that we have developed something that can help women avoid neural tube defects," says Dr. Sheldon P. Rothenberg, a professor of medicine and biochemistry at SUNY and leader of the research team.

The finding could lead to a test for the antibodies, to help identify women at high risk of neural tube defects."Companies may well want to develop such a test for clinical use," he says.
...
SOURCES: Sheldon P. Rothenberg, M.D., professor of medicine and biochemistry, State University of New York Downstate Medical Center, Brooklyn; Nancy Green, M.D., medical director, March of Dimes Birth Defects Foundation, White Plains, N.Y.; Jan. 8, 2004, New England Journal of Medicine

"The good thing is that we have developed something that can help women avoid neural tube defects," says Dr. Sheldon P. Rothenberg, a professor of medicine and biochemistry at SUNY and leader of the research team.

The finding could lead to a test for the antibodies, to help identify women at high risk of neural tube defects."Companies may well want to develop such a test for clinical use," he says.
...
SOURCES: Sheldon P. Rothenberg, M.D., professor of medicine and biochemistry, State University of New York Downstate Medical Center, Brooklyn; Nancy Green, M.D., medical director, March of Dimes Birth Defects Foundation, White Plains, N.Y.; Jan. 8, 2004, New England Journal of Medicine

"The good thing is that we have developed something that can help women avoid neural tube defects," says Dr. Sheldon P. Rothenberg, a professor of medicine and biochemistry at SUNY and leader of the research team.

The finding could lead to a test for the antibodies, to help identify women at high risk of neural tube defects."Companies may well want to develop such a test for clinical use," he says.

"The good thing is that we have developed something that can help women avoid neural tube defects," says Dr. Sheldon P. Rothenberg, a professor of medicine and biochemistry at SUNY and leader of the research team.The finding could lead to a test for the antibodies, to help identify women at high risk of neural tube defects."Companies may well want to develop such a test for clinical use," he says.